Recent advances and future directions in targeting the secretory apparatus in multiple myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 168, Issue 1, Pages 14-25
Publisher
Wiley
Online
2014-10-09
DOI
10.1111/bjh.13172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined autophagy and proteasome inhibition
- (2014) Dan T Vogl et al. Autophagy
- Enhanced rate of degradation of basic proteins by 26S immunoproteasomes
- (2014) Mary Raule et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome
- (2014) A. Brioli et al. BLOOD
- Endoplasmic Reticulum Stress in Malignancy
- (2014) Hanna J. Clarke et al. CANCER CELL
- Proteasome-Mediated Processing of Nrf1 Is Essential for Coordinate Induction of All Proteasome Subunits and p97
- (2014) Zhe Sha et al. CURRENT BIOLOGY
- Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma
- (2014) Sara Bringhen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Emerging therapies targeting the ubiquitin proteasome system in cancer
- (2014) Nathaniel M. Weathington et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes
- (2014) Gerjan de Bruin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cleaning up in the endoplasmic reticulum: ubiquitin in charge
- (2014) John C Christianson et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition
- (2014) Senthil K Radhakrishnan et al. eLife
- Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
- (2013) G. Mulligan et al. BLOOD
- Targeting the ubiquitin proteasome system in haematological malignancies
- (2013) Lisa J. Crawford et al. BLOOD REVIEWS
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- Histone Deacetylase Inhibitors in Multiple Myeloma: Rationale and Evidence for Their Use in Combination Therapy
- (2013) Jonathan L. Kaufman et al. Clinical Lymphoma Myeloma & Leukemia
- Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations
- (2013) Marianne Kraus et al. LEUKEMIA RESEARCH
- ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
- (2013) Jaeseok Han et al. NATURE CELL BIOLOGY
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- (2013) Paola Magnaghi et al. Nature Chemical Biology
- Plasma cells require autophagy for sustainable immunoglobulin production
- (2013) Niccolò Pengo et al. NATURE IMMUNOLOGY
- Autophagy in Human Health and Disease
- (2013) Augustine M.K. Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells
- (2013) Holger W. Auner et al. PLoS One
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
- (2013) M Kraus et al. Blood Cancer Journal
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Sequence analysis of -subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone
- (2012) D. I. Lichter et al. BLOOD
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Blockade of XBP1 splicing by inhibition of IRE1 is a promising therapeutic option in multiple myeloma
- (2012) N. Mimura et al. BLOOD
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- Thioredoxin-Interacting Protein Mediates ER Stress-Induced β Cell Death through Initiation of the Inflammasome
- (2012) Christine M. Oslowski et al. Cell Metabolism
- DangER: protein ovERload. Targeting protein degradation to treat myeloma
- (2012) L. I. Aronson et al. HAEMATOLOGICA
- High Rate of Antibody Secretion Is not Integral to Plasma Cell Differentiation as Revealed by XBP-1 Deficiency
- (2012) N. Taubenheim et al. JOURNAL OF IMMUNOLOGY
- Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors
- (2012) Simone Cenci et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Molecular mechanisms of effectiveness of novel therapies in multiple myeloma
- (2012) Giada Bianchi et al. LEUKEMIA & LYMPHOMA
- Failure of Amino Acid Homeostasis Causes Cell Death following Proteasome Inhibition
- (2012) Amila Suraweera et al. MOLECULAR CELL
- The Proteasome in Terminal Plasma Cell Differentiation
- (2012) Simone Cenci SEMINARS IN HEMATOLOGY
- Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells
- (2012) S Kawabata et al. Cell Death & Disease
- Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing
- (2012) M Ri et al. Blood Cancer Journal
- Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3
- (2011) J. D. Shaughnessy et al. BLOOD
- Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition
- (2011) J. Hu et al. BLOOD
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1
- (2011) S. C. W. Ling et al. HAEMATOLOGICA
- Metabolomics of B to Plasma Cell Differentiation
- (2011) Jose Manuel Garcia-Manteiga et al. JOURNAL OF PROTEOME RESEARCH
- Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
- (2011) Ira Tabas et al. NATURE CELL BIOLOGY
- Mice completely lacking immunoproteasomes show major changes in antigen presentation
- (2011) Eleanor Z Kincaid et al. NATURE IMMUNOLOGY
- Compromising the Unfolded Protein Response Induces Autophagy-Mediated Cell Death in Multiple Myeloma Cells
- (2011) Anne-Sophie Michallet et al. PLoS One
- Critical Role of VCP/p97 in the Pathogenesis and Progression of Non-Small Cell Lung Carcinoma
- (2011) Christopher W. Valle et al. PLoS One
- Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
- (2011) T.-F. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Ubiquitylation in ERAD: Reversing to Go Forward?
- (2011) Yien Che Tsai et al. PLOS BIOLOGY
- The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress
- (2010) H. W. Auner et al. BLOOD
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
- (2010) I. Papandreou et al. BLOOD
- Proteostenosis and plasma cell pathophysiology
- (2010) Simone Cenci et al. CURRENT OPINION IN CELL BIOLOGY
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- (2010) M Ri et al. LEUKEMIA
- Transcription Factor Nrf1 Mediates the Proteasome Recovery Pathway after Proteasome Inhibition in Mammalian Cells
- (2010) Senthil K. Radhakrishnan et al. MOLECULAR CELL
- Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop
- (2010) Janos Steffen et al. MOLECULAR CELL
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition
- (2009) G. Bianchi et al. BLOOD
- Plasma cell differentiation initiates a limited ER stress response by specifically suppressing the PERK-dependent branch of the unfolded protein response
- (2009) Yanjun Ma et al. CELL STRESS & CHAPERONES
- Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways
- (2009) Jenelle M. Timmins et al. JOURNAL OF CLINICAL INVESTIGATION
- Biogenesis of secretory organelles during B cell differentiation
- (2009) Semra J. Kirk et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells
- (2009) T Rückrich et al. LEUKEMIA
- Effect of autophagy on multiple myeloma cell viability
- (2009) B. Hoang et al. MOLECULAR CANCER THERAPEUTICS
- ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
- (2009) Q. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- One step at a time: endoplasmic reticulum-associated degradation
- (2008) Shruthi S. Vembar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started